Organogenesis Holdings (NASDAQ:ORGO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Organogenesis Holdings beat estimated earnings by 400.0%, reporting an EPS of $0.4 versus an estimate of $0.08.
Revenue was up $21.75 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 3.42% drop in the share price the next day.
Here's a look at Organogenesis Holdings's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | 0.07 | -0.02 | 0.13 |
| EPS Actual | 0.10 | 0.15 | 0.07 | 0.16 |
| Revenue Estimate | 112.67M | 107.30M | 87.57M | 99.18M |
| Revenue Actual | 113.75M | 123.20M | 102.55M | 106.81M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
